Vir Biotechnology, Inc. (VIR)

Vir Biotechnology Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Vir Biotechnology stock have an average target of 32.86, with a low estimate of 14 and a high estimate of 110. The average target predicts an increase of 520.00% from the current stock price of 5.30.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$14	$32.86	$20	$110
Change	+164.15%	+520.00%	+277.36%	+1975.5%

Analyst Ratings

The average analyst rating for Vir Biotechnology stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	2	2	2	2	3	3
Buy	1	3	3	3	3	3
Hold	2	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	6	6	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Stringer Needham	Needham	Strong Buy Maintains $19 → $14	Strong Buy	Maintains	$19 → $14	+164.15%	May 12, 2025
Paul Choi Goldman Sachs	Goldman Sachs	Strong Buy Maintains $28 → $21	Strong Buy	Maintains	$28 → $21	+296.23%	Apr 17, 2025
Gena Wang Barclays	Barclays	Buy Maintains $26 → $31	Buy	Maintains	$26 → $31	+484.91%	Feb 28, 2025
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $110	Strong Buy	Reiterates	$110	+1,975.47%	Feb 28, 2025
Joseph Stringer Needham	Needham	Strong Buy Reiterates $19	Strong Buy	Reiterates	$19	+258.49%	Feb 27, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

27.72M

Decreased by -62.64%

from 74.21M

Revenue Next Year

29.83M

Increased by 7.62%

from 27.72M

EPS This Year

-3.40

from -3.83

EPS Next Year

-3.10

from -3.40

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	76.37M	1.10B	1.62B	86.18M	74.21M	27.72M	29.83M	50.91M
Revenue Growth	843.86%	1,334.39%	47.50%	-94.67%	-13.90%	-62.64%	7.62%	70.64%
EPS	-2.51	3.96	3.83	-4.59	-3.83	-3.40	-3.10	-2.83
EPS Growth	-	-	-3.28%	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	9	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	111.5M	95.1M	158.8M
Avg	27.7M	29.8M	50.9M
Low	n/a	4.9M	11.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	50.3%	243.2%	432.1%
Avg	-62.6%	7.6%	70.6%
Low	-	-82.3%	-60.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.59	-2.48	-2.05
Avg	-3.40	-3.10	-2.83
Low	-3.79	-3.96	-4.35

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.